Revvity Inc. (NYSE:RVTY) — Market Cap & Net Worth
Market Cap & Net Worth: Revvity Inc. (RVTY)
Revvity Inc. (NYSE:RVTY) has a market capitalization of $11.22 Billion ($11.22 Billion) as of June 17, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #2080 globally and #770 in its home market, demonstrating a 2.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Revvity Inc.'s stock price $100.55 by its total outstanding shares 111559773 (111.56 Million). Review RVTY total debt and obligations to assess the company's total debt and financial obligations.
Revvity Inc. Market Cap History: 2015 to 2026
Revvity Inc.'s market capitalization history from 2015 to 2026. Data shows growth from $5.81 Billion to $11.22 Billion (7.28% CAGR).
Index Memberships
Revvity Inc. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$62.29 Trillion | 0.03% | #448 of 503 |
Weight: Revvity Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Revvity Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Revvity Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.78x
Revvity Inc.'s market cap is 3.78 times its annual revenue
Latest Price to Earnings (P/E) Ratio
44.66x
Revvity Inc.'s market cap is 44.66 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.69 Billion | $2.12 Billion | $233.68 Million | 2.69x | 24.34x |
| 2017 | $8.01 Billion | $2.26 Billion | $113.02 Million | 3.55x | 70.89x |
| 2018 | $8.64 Billion | $2.78 Billion | $238.79 Million | 3.11x | 36.17x |
| 2019 | $10.71 Billion | $2.88 Billion | $227.56 Million | 3.71x | 47.06x |
| 2020 | $15.87 Billion | $3.78 Billion | $728.10 Million | 4.20x | 21.80x |
| 2021 | $22.28 Billion | $3.83 Billion | $943.16 Million | 5.82x | 23.62x |
| 2022 | $15.57 Billion | $3.31 Billion | $569.18 Million | 4.70x | 27.35x |
| 2023 | $12.16 Billion | $2.75 Billion | -$118.38 Million | 4.42x | N/A |
| 2024 | $12.45 Billion | $2.76 Billion | $295.83 Million | 4.52x | 42.09x |
| 2025 | $10.79 Billion | $2.86 Billion | $241.68 Million | 3.78x | 44.66x |
Competitor Companies of RVTY by Market Capitalization
Companies near Revvity Inc. in the global market cap rankings as of June 17, 2026.
Key companies related to Revvity Inc. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.98 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #181 globally with a market cap of $127.92 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #622 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #662 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.98 Billion | $473.72 |
| #181 | Danaher Corporation | NYSE:DHR | $127.92 Billion | $181.10 |
| #622 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $570.00 |
| #662 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Revvity Inc. Historical Marketcap From 2015 to 2026
Between 2015 and today, Revvity Inc.'s market cap moved from $5.81 Billion to $ 11.22 Billion, with a yearly change of 7.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $11.22 Billion | +3.93% |
| 2025 | $10.79 Billion | -13.31% |
| 2024 | $12.45 Billion | +2.37% |
| 2023 | $12.16 Billion | -21.87% |
| 2022 | $15.57 Billion | -30.13% |
| 2021 | $22.28 Billion | +40.37% |
| 2020 | $15.87 Billion | +48.20% |
| 2019 | $10.71 Billion | +24.01% |
| 2018 | $8.64 Billion | +7.80% |
| 2017 | $8.01 Billion | +40.85% |
| 2016 | $5.69 Billion | -2.12% |
| 2015 | $5.81 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Revvity Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.22 Billion USD |
| MoneyControl | $11.22 Billion USD |
| MarketWatch | $11.22 Billion USD |
| marketcap.company | $11.22 Billion USD |
| Reuters | $11.22 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Revvity Inc.
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectio… Read more